Page 11 - Dbv Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AMF Regulated InformationMontrouge, France, January 23, 2023 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies...

DBV Technologies (NASDAQ:DBVT – Get Rating) was downgraded by stock analysts at The Goldman Sachs Group from a “neutral” rating to a “sell” rating in a research note issued to investors on Friday, Marketbeat.com reports. Separately, StockNews.com assumed coverage on shares of DBV Technologies in a research note on Friday. They issued a “sell” rating […]

DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 3,520,000 shares, an increase of 125.6% from the May 31st total of 1,560,000 shares. Based on an average daily trading volume, of 714,500 shares, the short-interest ratio […]

DBV Technologies (NASDAQ:DBVT – Get Rating) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Valuation and Earnings This table compares DBV Technologies […]

StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report issued on Sunday morning. The brokerage issued a hold rating on the stock. A number of other research analysts also recently issued reports on the company. HC Wainwright reaffirmed a buy rating and set a $10.00 price target on shares […]